Alexander Straub

Probably Genetic helps undiagnosed rare disease patients find answers to their symptoms in a matter of weeks. There are over 400 million people worldwide that have a rare disease — more than cancer and HIV patients combined. Half of those patients are currently undiagnosed and half of them are children, and it takes 5-7 years on average for these patients to get a diagnosis. With our system, patients can get answers in a matter of weeks. Our online Symptom Checker identifies rare disease patients using state-of-the-art machine learning models, gets them tested through our direct-to-consumer genetic testing service, and helps connect these patients to potentially life-saving treatments and advocacy communities. We partner with drug developers to offer sponsored testing programs that allow patients to access genetic testing for little to no cost.

SNAPME LTD is a company based out of London/Berlin, United Kingdom.

Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford. We combine our unique automation platform, Ulysses, with a world-class team of excellent laboratory scientists to guide and rapidly progress our partners’ drug discovery programs from target to candidate. Data is the lifeblood of research, and “Better Data leads to Better Decisions”. Our excellent service is built on: 1) Data quality: generating large reproducible datasets by leveraging robotics and wet lab automation, in turn empowering improved decision-making. 2) Our world-class team of experienced scientists: a true partner for your discovery work, consulting and advising on assay cascades and the path from target all the way to the clinic. 3) An "ecosystem of excellence”: we are a full-suite discovery PRO with partners in all adjacent disciplines, which allows us to stay agile and truly client-focused.

Summit Mission Statement To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, and successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy* intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when appropriate. We accomplish this by building a team of world class professional scientists and business administrators that apply their experience and knowledge to this mission. Team Summit exists to pose, strategize, and execute a path forward in medicinal therapeutic health care that places Summit in a well-deserved, top market share, leadership position. Team Summit assumes full responsibility for stimulating continuous expansion of knowledge, ability, capability, and well-being for all involved stakeholders and highly-valued shareholders. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK and Cambridge, UK. *For our purposes, friendly medicinal therapy is defined as follows: therapeutic efficacy (cure with duration and without recurrence and resistance) over therapeutic trauma. Therapeutic trauma is defined as serious side effects while on therapy or post-therapy but related to therapy, disease recurrence, patient non–compliance with daily dosage due to challenges associated with our therapy, its affordability, or accessibility.

WE’RE ON A MISSION TO CONNECT THE WORLD SEAMLESSLY That’s why we aim to enable more connections than anyone else and why we’ve been pioneering the eSIM revolution from the very beginning. From international enterprises and consumers to IOT device makers and Telecommunications operators, our global network and connectivity solutions enable people, devices and networks to connect anywhere, instantly, with one platform to connect billions. Headquartered in the UK and with offices across four continents, we’ve invested over £550 million in building our unique proposition and becoming one of the world’s leading innovators in eSIM, cloud and digital solutions. As a result, we’ve become a leading technology company and eSIM trailblazer that’s trusted by thousands of international businesses across hundreds of countries, including global brands, powerhouse network providers and leading banks and financial institutions. One truly global network. One global supplier. One complete solution that revolutionises the world of connectivity and connects people, devices and networks seamlessly all around the world. Because we believe that the better the world communicates, the better the world.

net mobile AG is a leading international full-service provider of payment solutions and mobile value added services. The company, founded in November 2000, is regarded as an innovation leader in the marketplace. Clients worldwide include national and global mobile telecommunication providers, media companies, online shopping portals, brand name companies and television networks, for which complete white label solutions such as direct carrier billing and mobile television services are provided. Since December 2009, NTT DOCOMO, INC. is the main shareholder with over 87% share ownership. For more information please visit www.net-mobile.com. Legal Notice: http://www.net-mobile.com/en/footer/legal-notice/

IBX Business Network is part of the Capgemini Group, one of the world's foremost providers of consulting, technology and outsourcing services. Together with its clients, Capgemini creates and delivers business and technology solutions that fit their needs and drive the results they want. A deeply multicultural organization, Capgemini has developed its own way of working, the Collaborative Business Experience™, and draws on Rightshore®, its worldwide delivery model. Connecting over 350 large buying organizations, 550 000 suppliers and providing services in more than 100 geographies, the IBX Business Network is a Cloud-based, ERP independent, e-Procurement platform that optimizes user-experience, enables superior spend management, while exacting lower total cost of ownership. Part of Capgemini’s BPO portfolio, the IBX Business Network is a complete ready-to-run procurement service that supports the entire closed-loop Source-Purchase-Pay process, resulting in lower costs and faster ROI, increased spend visibility and transparency, increased control and compliance and improved supplier quality.

At the heart of the global marketplace are the billions of transactions that happen every day. There are multiple human touch-points between Buyers and Suppliers — each of which cost time and the possibility of human error. Increasing demands for compliance bring ever more intricate regulation. In response, businesses today are searching for ways to streamline and become more agile. Trusted, passionate and proven, Tungsten Network makes the digitisation of commerce faster, easier and smarter between Buyers and Suppliers around the world. Our network has built a community with over half the Fortune 500 and is easing the accounts payable process with higher visibility, greater insights and unprecedented speed. The future of the global marketplace is here.

Probably Genetic helps undiagnosed rare disease patients find answers to their symptoms in a matter of weeks. There are over 400 million people worldwide that have a rare disease — more than cancer and HIV patients combined. Half of those patients are currently undiagnosed and half of them are children, and it takes 5-7 years on average for these patients to get a diagnosis. With our system, patients can get answers in a matter of weeks. Our online Symptom Checker identifies rare disease patients using state-of-the-art machine learning models, gets them tested through our direct-to-consumer genetic testing service, and helps connect these patients to potentially life-saving treatments and advocacy communities. We partner with drug developers to offer sponsored testing programs that allow patients to access genetic testing for little to no cost.

SNAPME LTD is a company based out of London/Berlin, United Kingdom.

Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford. We combine our unique automation platform, Ulysses, with a world-class team of excellent laboratory scientists to guide and rapidly progress our partners’ drug discovery programs from target to candidate. Data is the lifeblood of research, and “Better Data leads to Better Decisions”. Our excellent service is built on: 1) Data quality: generating large reproducible datasets by leveraging robotics and wet lab automation, in turn empowering improved decision-making. 2) Our world-class team of experienced scientists: a true partner for your discovery work, consulting and advising on assay cascades and the path from target all the way to the clinic. 3) An "ecosystem of excellence”: we are a full-suite discovery PRO with partners in all adjacent disciplines, which allows us to stay agile and truly client-focused.

Empora Group is a technology enterprise that is driving a new era of fashion consumerism. The group comprises a set of applications & enabling technologies, which collectively focus on fashion sales lead generation. Through various key strategic acquisitions, a number of technology companies have been brought together to form Empora Group. Empora Group GmbH is based in Wismar, Germany since 2010.